Python remains on top despite another dip; C gains ground in second place, and April keeps the same top 10 order, with SQL, R, and Delphi holding steady. April’s TIOBE Index keeps the same cast in the ...

At least a dozen large Indian drugmakers are set to roll out copies of Novo Nordisk A/S’s blockbuster weight-loss drugs as soon as the patent expires Friday, crashing prices in the country with the ...

The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this weekend to start selling generic versions of Ozempic and Wegovy, with several ...

GLP-1 drugs like semaglutide (sold as Ozempic and Wegovy) are so successful that they have redefined what the pharmaceutical industry calls a “blockbuster”. Few prescription drugs have moved from ...

Marion Bradley, 57, filling a prescription for one of her customers . She is the lead pharmacist and co-owner of Beacon Falls Pharmacy. Credit: Carl Jordan Castro / C-HIT.org India supplies nearly ...

Ritwik is a passionate gamer who has a soft spot for JRPGs. He's been writing about all things gaming for six years and counting. No matter how great a title's gameplay may be, there's always the ...

With Rinvoq and its sibling medicine Skyrizi having successfully picked up the sales torch in the wake of Humira’s tumble over the patent cliff, AbbVie is working to cover its legal bases so the ...

gen is a generic general use Go functions library with the intention of replacing duplicated code where the same functionality is needed across multiple types, and provides a common interface for the ...

The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the treatment ...

In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday approved a second generic in the category of medications known as GLP-1s.

The Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug Victoza, which is currently in shortage in the country. Subscribe to read ...